These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32714120)

  • 1. The Heterogeneous Landscape and Early Evolution of Pathogen-Associated CpG Dinucleotides in SARS-CoV-2.
    Di Gioacchino A; Šulc P; Komarova AV; Greenbaum BD; Monasson R; Cocco S
    SSRN; 2020 May; ():3611280. PubMed ID: 32714120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Heterogeneous Landscape and Early Evolution of Pathogen-Associated CpG Dinucleotides in SARS-CoV-2.
    Di Gioacchino A; Šulc P; Komarova AV; Greenbaum BD; Monasson R; Cocco S
    Mol Biol Evol; 2021 May; 38(6):2428-2445. PubMed ID: 33555346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The heterogeneous landscape and early evolution of pathogen-associated CpG dinucleotides in SARS-CoV-2.
    Di Gioacchino A; Šulc P; Komarova AV; Greenbaum BD; Monasson R; Cocco S
    bioRxiv; 2020 Dec; ():. PubMed ID: 32511407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 Is Restricted by Zinc Finger Antiviral Protein despite Preadaptation to the Low-CpG Environment in Humans.
    Nchioua R; Kmiec D; Müller JA; Conzelmann C; Groß R; Swanson CM; Neil SJD; Stenger S; Sauter D; Münch J; Sparrer KMJ; Kirchhoff F
    mBio; 2020 Oct; 11(5):. PubMed ID: 33067384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 and other human coronavirus show genome patterns previously associated to reduced viral recognition and altered immune response.
    Franzo G
    Sci Rep; 2021 May; 11(1):10696. PubMed ID: 34021237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extreme Genomic CpG Deficiency in SARS-CoV-2 and Evasion of Host Antiviral Defense.
    Xia X
    Mol Biol Evol; 2020 Sep; 37(9):2699-2705. PubMed ID: 32289821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronavirus genomes carry the signatures of their habitats.
    Wei Y; Silke JR; Aris P; Xia X
    PLoS One; 2020; 15(12):e0244025. PubMed ID: 33351847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Slowing Rate of CpG Depletion in SARS-CoV-2 Genomes Is Consistent with Adaptations to the Human Host.
    Kumar A; Goyal N; Saranathan N; Dhamija S; Saraswat S; Menon MB; Vivekanandan P
    Mol Biol Evol; 2022 Mar; 39(3):. PubMed ID: 35134218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 will constantly sweep its tracks: a vaccine containing CpG motifs in 'lasso' for the multi-faced virus.
    Oberemok VV; Laikova KV; Yurchenko KA; Marochkin NA; Fomochkina II; Kubyshkin AV
    Inflamm Res; 2020 Sep; 69(9):801-812. PubMed ID: 32656668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 within-host diversity of human hosts and its implications for viral immune evasion.
    Xi B; Zeng X; Chen Z; Zeng J; Huang L; Du H
    mBio; 2023 Aug; 14(4):e0067923. PubMed ID: 37273216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The low abundance of CpG in the SARS-CoV-2 genome is not an evolutionarily signature of ZAP.
    Afrasiabi A; Alinejad-Rokny H; Khosh A; Rahnama M; Lovell N; Xu Z; Ebrahimi D
    Sci Rep; 2022 Feb; 12(1):2420. PubMed ID: 35165300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does the Zinc Finger Antiviral Protein (ZAP) Shape the Evolution of Herpesvirus Genomes?
    Lin YT; Chau LF; Coutts H; Mahmoudi M; Drampa V; Lee CH; Brown A; Hughes DJ; Grey F
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of human coronaviruses focusing on nucleotide variability and synonymous codon usage patterns.
    Das JK; Roy S
    Genomics; 2021 Jul; 113(4):2177-2188. PubMed ID: 34019999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rampant C→U Hypermutation in the Genomes of SARS-CoV-2 and Other Coronaviruses: Causes and Consequences for Their Short- and Long-Term Evolutionary Trajectories.
    Simmonds P
    mSphere; 2020 Jun; 5(3):. PubMed ID: 32581081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-genome variability in the dinucleotide composition of SARS-CoV-2.
    Digard P; Lee HM; Sharp C; Grey F; Gaunt E
    Virus Evol; 2020 Jul; 6(2):veaa057. PubMed ID: 33029383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability in Codon Usage in Coronaviruses Is Mainly Driven by Mutational Bias and Selective Constraints on CpG Dinucleotide.
    Daron J; Bravo IG
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Genomics and Integrated Network Approach Unveiled Undirected Phylogeny Patterns, Co-mutational Hot Spots, Functional Cross Talk, and Regulatory Interactions in SARS-CoV-2.
    Gupta V; Haider S; Verma M; Singhvi N; Ponnusamy K; Malik MZ; Verma H; Kumar R; Sood U; Hira P; Satija S; Singh Y; Lal R
    mSystems; 2021 Feb; 6(1):. PubMed ID: 33622851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Strategies of Antiviral Drug Discovery for COVID-19.
    Mei M; Tan X
    Front Mol Biosci; 2021; 8():671263. PubMed ID: 34055887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properties of Coronavirus and SARS-CoV-2.
    Malik YA
    Malays J Pathol; 2020 Apr; 42(1):3-11. PubMed ID: 32342926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Long-Term Evolutionary History of Gradual Reduction of CpG Dinucleotides in the SARS-CoV-2 Lineage.
    Subramanian S
    Biology (Basel); 2021 Jan; 10(1):. PubMed ID: 33445785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.